Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
Publication stageIn Press Journal Pre-Proof
Conflict of Interest/Disclosure Statement: All authors declare they have no actual or potential competing financial interests.
Study Funding: None to report.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Condensation: Using national data (2016-2018), our study provides the most up-to-date estimates of cumulative chance of live birth based on demographic and reproductive characteristics.
AJOG at a Glance.
A. Why was this study conducted?
•As the use of in vitro fertilization continues to increase in the US, models that estimate cumulative live birth rates are valuable for patients and clinicians weighing treatment options. The goal of this analysis was provide individualized estimates of cumulative live birth rates for individuals considering IVF using national surveillance data from 2016-2018 in the United States.
B. What are the key findings?
•In this population-based cohort of over 200,000 patients undergoing in vitro fertilization in the United States, our models had high discrimination for estimating cumulative probability of live birth in new and return autologous (but not donor) oocyte patients.
C. What does this study add to what is already known?
•Our models provide individualized estimates of cumulative chance of a live birth to help inform patients and providers of a woman’s likelihood of success following in vitro fertilization.